In our latest quarterly review of corporate sustainability impacts, risks and opportunities, we find that biotechnology and pharmaceutical companies have made substantial ESG commitments. This edition also analyses the effects of government tariffs and trade policy uncertainty on sustainable API sourcing and green manufacturing transitions.
This report analyses thousands of sustainability disclosures from 20 leading entities in the industry, including Johnson & Johnson, Roche Holding and Pfizer. The report now integrates government tariffs and trade policy uncertainty as factors in sustainability disclosures and supply chain risk management.
- 1. Nature and climate risks
- 2. Value chain: upstream
- 3. Value chain: downstream
- 4. Planet-Environmental impacts
- 5. People-Social and governance impacts
- 6.UN Sustainable Development Goals
- 7. Technology
- 8. Finance
- 9. Policy
- 10. Calendar of events
- 11. Risks profile
- 12. Industry sustainability highlights
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook